Published in Cancer Weekly, May 15th, 1995
"In patients with prostate cancer, testosterone-suppressing medications may cause, among other things, shrinkage of the tumor," said Dr. Mark Soloway, chairman of the Department of Urology at the University of Miami School of Medicine, Florida. "This could enhance the surgeon's ability to remove all of the cancerous tissue and make for improved surgical results."
Soloway's information came from what he called the largest prospective, randomized, multi-center study of its kind. He...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.